{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:33:08Z","timestamp":1794313988711,"version":"4.9.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A2A3075038"],"award-info":[{"award-number":["2018R1A2A3075038"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nonalcoholic fatty liver disease (NAFLD) is an important health concern worldwide and progresses into nonalcoholic steatohepatitis (NASH). Although prevalence and severity of NAFLD\/NASH are higher in men than premenopausal women, it remains unclear how sex affects NAFLD\/NASH pathophysiology. Formyl peptide receptor 2 (FPR2) modulates inflammatory responses in several organs; however, its role in the liver is unknown. Here we show that FPR2 mediates sex-specific responses to diet-induced NAFLD\/NASH. NASH-like liver injury was induced in both sexes during choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) feeding, but compared with females, male mice had more severe hepatic damage. Fpr2 was more highly expressed in hepatocytes and healthy livers from females than males, and FPR2 deletion exacerbated liver damage in CDAHFD-fed female mice. Estradiol induced Fpr2 expression, which protected hepatocytes and the liver from damage. In conclusion, our results demonstrate that FPR2 mediates sex-specific responses to diet-induced NAFLD\/NASH, suggesting a novel therapeutic target for NAFLD\/NASH.<\/jats:p>","DOI":"10.1038\/s41467-022-28138-6","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T06:18:07Z","timestamp":1643609887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5680-9613","authenticated-orcid":false,"given":"Chanbin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5317-9409","authenticated-orcid":false,"given":"Jinsol","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2096-4419","authenticated-orcid":false,"given":"Hayeong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0507-8689","authenticated-orcid":false,"given":"Sang-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6825-0407","authenticated-orcid":false,"given":"Jeong Nam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Su","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4323-4790","authenticated-orcid":false,"given":"Jae Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-0658","authenticated-orcid":false,"given":"Youngmi","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"28138_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"28138_CR2","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s10620-016-4143-0","volume":"61","author":"ZA Sherif","year":"2016","unstructured":"Sherif, Z. A. et al. Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations. Dig. Dis. Sci. 61, 1214\u20131225 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"28138_CR3","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jhep.2015.02.041","volume":"62","author":"V Ratziu","year":"2015","unstructured":"Ratziu, V., Goodman, Z. & Sanyal, A. Current efforts and trends in the treatment of NASH. J. Hepatol. 62, S65\u2013S75 (2015).","journal-title":"J. Hepatol."},{"key":"28138_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00535-010-0311-8","volume":"46","author":"E Hashimoto","year":"2011","unstructured":"Hashimoto, E. & Tokushige, K. Prevalence, gender, ethnic variations, and prognosis of NASH. J. Gastroenterol. 46, 63\u201369 (2011).","journal-title":"J. Gastroenterol."},{"key":"28138_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","volume":"155","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez, E. et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology 155, 443\u2013457.e417 (2018).","journal-title":"Gastroenterology"},{"key":"28138_CR6","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/liv.13709","volume":"38","author":"MT Long","year":"2018","unstructured":"Long, M. T. et al. A simple clinical model predicts incident hepatic steatosis in a community-based cohort: the Framingham heart study. Liver Int. 38, 1495\u20131503 (2018).","journal-title":"Liver Int."},{"key":"28138_CR7","doi-asserted-by":"crossref","unstructured":"Im H. J., Ahn Y. C., Wang J. H., Lee M. M., Son C. G. Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea. Clin. Res. Hepatol. Gastroenterol. 45, 101526 (2020).","DOI":"10.1016\/j.clinre.2020.06.022"},{"key":"28138_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","volume":"18","author":"M Hamaguchi","year":"2012","unstructured":"Hamaguchi, M. et al. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J. Gastroenterol. 18, 237\u2013243 (2012).","journal-title":"World J. Gastroenterol."},{"key":"28138_CR9","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.3748\/wjg.v13.i47.6419","volume":"13","author":"YJ Zhou","year":"2007","unstructured":"Zhou, Y. J. et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J. Gastroenterol. 13, 6419\u20136424 (2007).","journal-title":"World J. Gastroenterol."},{"key":"28138_CR10","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1053\/gast.2002.33573","volume":"122","author":"JM Clark","year":"2002","unstructured":"Clark, J. M., Brancati, F. L. & Diehl, A. M. Nonalcoholic fatty liver disease. Gastroenterology 122, 1649\u20131657 (2002).","journal-title":"Gastroenterology"},{"key":"28138_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15009-1","volume":"11","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. Structural basis of ligand binding modes at the human formyl peptide receptor 2. Nat. Commun. 11, 1208 (2020).","journal-title":"Nat. Commun."},{"key":"28138_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jaut.2017.06.012","volume":"85","author":"K Chen","year":"2017","unstructured":"Chen, K. et al. Regulation of inflammation by members of the formyl-peptide receptor family. J. Autoimmun. 85, 64\u201377 (2017).","journal-title":"J. Autoimmun."},{"key":"28138_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cmet.2015.05.003","volume":"22","author":"E B\u00f6rgeson","year":"2015","unstructured":"B\u00f6rgeson, E. et al. Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease. Cell Metab. 22, 125\u2013137 (2015).","journal-title":"Cell Metab."},{"key":"28138_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/hep.27141","volume":"60","author":"I Locatelli","year":"2014","unstructured":"Locatelli, I. et al. Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. Hepatology 60, 531\u2013544 (2014).","journal-title":"Hepatology"},{"key":"28138_CR15","doi-asserted-by":"publisher","first-page":"e100522","DOI":"10.1371\/journal.pone.0100522","volume":"9","author":"A Giebeler","year":"2014","unstructured":"Giebeler, A. et al. Deficiency of formyl peptide receptor 1 and 2 is associated with increased inflammation and enhanced liver injury after LPS-stimulation. PloS One 9, e100522\u2013e100522 (2014).","journal-title":"PloS One"},{"key":"28138_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","volume":"125","author":"AE Feldstein","year":"2003","unstructured":"Feldstein, A. E. et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125, 437\u2013443 (2003).","journal-title":"Gastroenterology"},{"key":"28138_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1586\/egh.11.6","volume":"5","author":"N Alkhouri","year":"2011","unstructured":"Alkhouri, N., Carter-Kent, C. & Feldstein, A. E. Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Exp. Rev. Gastroenterol. Hepatol. 5, 201\u2013212 (2011).","journal-title":"Exp. Rev. Gastroenterol. Hepatol."},{"key":"28138_CR18","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado, M. V. & Diehl, A. M. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 150, 1769\u20131777 (2016).","journal-title":"Gastroenterology"},{"key":"28138_CR19","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","volume":"61","author":"M Arrese","year":"2016","unstructured":"Arrese, M., Cabrera, D., Kalergis, A. M. & Feldstein, A. E. Innate immunity and inflammation in NAFLD\/NASH. Dig. Dis. Sci. 61, 1294\u20131303 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"28138_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1053\/j.gastro.2015.05.039","volume":"149","author":"SA Xanthakos","year":"2015","unstructured":"Xanthakos, S. A. et al. High prevalence of nonalcoholic fatty liver disease in adolescents undergoing bariatric surgery. Gastroenterology 149, 623\u2013634.e628 (2015).","journal-title":"Gastroenterology"},{"key":"28138_CR21","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/cells8101259","volume":"8","author":"C Lee","year":"2019","unstructured":"Lee, C., Kim, J. & Jung, Y. Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Cells 8, 1259 (2019).","journal-title":"Cells"},{"key":"28138_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/j.gastro.2016.09.017","volume":"152","author":"A Besse-Patin","year":"2017","unstructured":"Besse-Patin, A. et al. Estrogen signals through peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 to reduce oxidative damage associated with diet-induced fatty liver disease. Gastroenterology 152, 243\u2013256 (2017).","journal-title":"Gastroenterology"},{"key":"28138_CR23","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/hep.23094","volume":"50","author":"K Fujita","year":"2009","unstructured":"Fujita, K. et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 50, 772\u2013780 (2009).","journal-title":"Hepatology"},{"key":"28138_CR24","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/S0021-9258(18)69166-5","volume":"263","author":"ZM Yao","year":"1988","unstructured":"Yao, Z. M. & Vance, D. E. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J. Biol. Chem. 263, 2998\u20133004 (1988).","journal-title":"J. Biol. Chem."},{"key":"28138_CR25","first-page":"125","volume":"76","author":"L Tessitore","year":"1995","unstructured":"Tessitore, L., Sesca, E., Greco, M., Pani, P. & Dianzani, M. U. Sexually differentiated response to choline in choline deficiency and ethionine intoxication. Int. J. Exp. Pathol. 76, 125\u2013129 (1995).","journal-title":"Int. J. Exp. Pathol."},{"key":"28138_CR26","doi-asserted-by":"publisher","first-page":"21851","DOI":"10.1074\/jbc.M301982200","volume":"278","author":"AA Noga","year":"2003","unstructured":"Noga, A. A. & Vance, D. E. A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice. J. Biol. Chem. 278, 21851\u201321859 (2003).","journal-title":"J. Biol. Chem."},{"key":"28138_CR27","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1096\/fj.07-8227com","volume":"21","author":"M Resseguie","year":"2007","unstructured":"Resseguie, M. et al. Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. FASEB J. 21, 2622\u20132632 (2007).","journal-title":"FASEB J."},{"key":"28138_CR28","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.26761","volume":"59","author":"JD Yang","year":"2014","unstructured":"Yang, J. D. et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology 59, 1406\u20131414 (2014).","journal-title":"Hepatology"},{"key":"28138_CR29","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/1535370215570189","volume":"240","author":"G Xin","year":"2015","unstructured":"Xin, G. et al. Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway. Exp. Biol. Med. 240, 1279\u20131286 (2015).","journal-title":"Exp. Biol. Med."},{"key":"28138_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","volume":"21","author":"SH Park","year":"2006","unstructured":"Park, S. H. et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21, 138\u2013143 (2006).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"28138_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/hep.20543","volume":"41","author":"A Suzuki","year":"2005","unstructured":"Suzuki, A. et al. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 41, 64\u201371 (2005).","journal-title":"Hepatology"},{"key":"28138_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto, M. et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int. J. Exp. Pathol. 94, 93\u2013103 (2013).","journal-title":"Int. J. Exp. Pathol."},{"key":"28138_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/iep.12240","volume":"98","author":"A Ikawa-Yoshida","year":"2017","unstructured":"Ikawa-Yoshida, A. et al. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet. Int. J. Exp. Pathol. 98, 221\u2013233 (2017).","journal-title":"Int. J. Exp. Pathol."},{"key":"28138_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3892\/ijmm.2016.2483","volume":"37","author":"X Jiang","year":"2016","unstructured":"Jiang, X. et al. Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-\u03baB pathway. Int. J. Mol. Med. 37, 773\u2013780 (2016).","journal-title":"Int. J. Mol. Med."},{"key":"28138_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.5152\/tjg.2019.18276","volume":"30","author":"EL Kurto\u011flu","year":"2019","unstructured":"Kurto\u011flu, E. L. et al. A bioactive product lipoxin A4 attenuates liver fibrosis in an experimental model by regulating immune response and modulating the expression of regeneration genes. Turk. J. Gastroenterol. 30, 745\u2013757 (2019).","journal-title":"Turk. J. Gastroenterol."},{"key":"28138_CR36","doi-asserted-by":"publisher","first-page":"294278","DOI":"10.1155\/2015\/294278","volume":"2015","author":"M Shen","year":"2015","unstructured":"Shen, M. & Shi, H. Sex hormones and their receptors regulate liver energy homeostasis. Int. J. Endocrinol. 2015, 294278 (2015).","journal-title":"Int. J. Endocrinol."},{"key":"28138_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/rmb2.12006","volume":"16","author":"P Yasar","year":"2017","unstructured":"Yasar, P., Ayaz, G., User, S. D., Gupur, G. & Muyan, M. Molecular mechanism of estrogen-estrogen receptor signaling. Reprod. Med. Biol. 16, 4\u201320 (2017).","journal-title":"Reprod. Med. Biol."},{"key":"28138_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/gtc.12214","volume":"20","author":"T Uebi","year":"2015","unstructured":"Uebi, T., Umeda, M. & Imai, T. Estrogen induces estrogen receptor alpha expression and hepatocyte proliferation in the livers of male mice. Genes Cells 20, 217\u2013223 (2015).","journal-title":"Genes Cells"},{"key":"28138_CR39","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/jgh.13976","volume":"33","author":"B Zhang","year":"2018","unstructured":"Zhang, B., Zhang, C. G., Ji, L. H., Zhao, G. & Wu, Z. Y. Estrogen receptor \u03b2 selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells. J. Gastroenterol. Hepatol. 33, 747\u2013755 (2018).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"28138_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2535\/ofaj1936.65.1_35","volume":"65","author":"K Kimura","year":"1988","unstructured":"Kimura, K. & Takeuchi, K. Aging and longevity of the Jel: ICR mouse. Okajimas Folia Anat. Jpn. 65, 35\u201342 (1988).","journal-title":"Okajimas Folia Anat. Jpn."},{"key":"28138_CR41","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1074\/jbc.M114.592352","volume":"290","author":"AM Pierdomenico","year":"2015","unstructured":"Pierdomenico, A. M. et al. MicroRNA-181b regulates ALX\/FPR2 receptor expression and proresolution signaling in human macrophages. J. Biol. Chem. 290, 3592\u20133600 (2015).","journal-title":"J. Biol. Chem."},{"key":"28138_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14055-y","volume":"7","author":"AM Pierdomenico","year":"2017","unstructured":"Pierdomenico, A. M. & Patruno, S. microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A(4) receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. Sci. Rep. 7, 13519 (2017).","journal-title":"Sci. Rep."},{"key":"28138_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.bbrc.2017.09.042","volume":"493","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1. Biochem. Biophys. Res. Commun. 493, 227\u2013232 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"28138_CR44","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/onc.2009.468","volume":"29","author":"B Wang","year":"2010","unstructured":"Wang, B. et al. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29, 1787\u20131797 (2010).","journal-title":"Oncogene"},{"key":"28138_CR45","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbalip.2011.09.009","volume":"1821","author":"LK Cole","year":"2012","unstructured":"Cole, L. K., Vance, J. E. & Vance, D. E. Phosphatidylcholine biosynthesis and lipoprotein metabolism. Biochim. Biophys. Acta 1821, 754\u2013761 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"28138_CR46","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/ajcn\/85.5.1275","volume":"85","author":"LM Fischer","year":"2007","unstructured":"Fischer, L. M. et al. Sex and menopausal status influence human dietary requirements for the nutrient choline. Am. J. Clin. Nutr. 85, 1275\u20131285 (2007).","journal-title":"Am. J. Clin. Nutr."},{"key":"28138_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2010.06.021","volume":"54","author":"C Garc\u00eda-Monz\u00f3n","year":"2011","unstructured":"Garc\u00eda-Monz\u00f3n, C. et al. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C. J. Hepatol. 54, 142\u2013152 (2011).","journal-title":"J. Hepatol."},{"key":"28138_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep05832","volume":"4","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. Sci. Rep. 4, 5832 (2014).","journal-title":"Sci. Rep."},{"key":"28138_CR49","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/gut.2009.204354","volume":"59","author":"Y Jung","year":"2010","unstructured":"Jung, Y. et al. Signals from dying hepatocytes trigger growth of liver progenitors. Gut 59, 655\u2013665 (2010).","journal-title":"Gut"},{"key":"28138_CR50","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.4049\/jimmunol.0903526","volume":"184","author":"N Dufton","year":"2010","unstructured":"Dufton, N. et al. Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J. Immunol. 184, 2611\u20132619 (2010).","journal-title":"J. Immunol."},{"key":"28138_CR51","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/15287397909529766","volume":"5","author":"PO Seglen","year":"1979","unstructured":"Seglen, P. O. Hepatocyte suspensions and cultures as tools in experimental carcinogenesis. J. Toxicol. Environ. Health 5, 551\u2013560 (1979).","journal-title":"J. Toxicol. Environ. Health"},{"key":"28138_CR52","doi-asserted-by":"publisher","first-page":"119375","DOI":"10.1016\/j.biomaterials.2019.119375","volume":"219","author":"S Wang","year":"2019","unstructured":"Wang, S. et al. Tumor necrosis factor-inducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse. Biomaterials 219, 119375 (2019).","journal-title":"Biomaterials"},{"key":"28138_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10993","volume":"7","author":"J Hyun","year":"2016","unstructured":"Hyun, J. et al. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat. Commun. 7, 10993 (2016).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28138-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28138-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T11:17:12Z","timestamp":1669288632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28138-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28138"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28138-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"assertion":[{"value":"19 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"578"}}